Yashraj Biotechnology Ltd Email Format
Biotechnology ResearchMaharashtra, India201-500 Employees
Yashraj Biotechnology Ltd (YBL) operates in biotechnology research and specializes in producing high-purity antigens and antibodies for the global In Vitro Diagnostics (IVD) market. Established in 1999 and headquartered in Navi Mumbai, Maharashtra, the company is ISO 13485:2016 and ISO 9001:2015 certified, reflecting its commitment to quality. Its catalog includes native and recombinant antigens as well as polyclonal and monoclonal antibodies across clinical areas such as oncology, cardiovascular health, inflammation, infectious diseases, and metabolic disorders, including markers like CRP, Troponin I, NT-proBNP, PCT, CA125, CA15-3, and CA19-9. YBL emphasizes access to large volumes of diverse clinical samples from its network of hospitals in India, enabling the purification of native antigens from human sources and supporting a bench-to-bedside approach. With a 200,000 sq ft manufacturing footprint across four sites and facilities for mammalian and microbial expression, plus a dedicated goat polyclonal antibody operation, the company positions itself as a reliable supplier of batch-to-batch consistent raw materials to global IVD manufacturers with more than two decades of experience.